- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Aurobindo Pharma Limited — Important, 26-05-2025: Updates
26-05-2025 | 08:06 pm
26-05-2025 | 08:06 pm
Aurobindo Pharma has announced a board meeting to approve the financial results for the quarter and year ended March 31, 2025. The audit reports by Deloitte carry unmodified opinions. The company plans to seek shareholder approval to raise existing financial limits and has appointed MRR & Associates as Secretarial Auditors for five years starting FY 2025-26, pending shareholder consent.
No comments yet. Be the first to comment!